S. 251 · 110th Congress

Pharmaceutical Market Access Act of 2007

Stage: In committee
Sponsor: David Vitter
Introduced: 2007-01-10
Latest action: 2007-01-10 · Introduced in Senate

Subjects

Congress

Israel

Health

Europe

Norway

Civil actions and liability

Law

Japan

Italy

United Kingdom

Department of Health and Human Services

Australia

Oceania

Commerce

Germany

Intellectual property

Canada

Greece

South Africa

New Zealand

Business records

Ireland

Sweden

Netherlands

Administrative remedies

France

Science, Technology, Communications

Government Operations and Politics

Switzerland

Economics and Public Finance

Congressional reporting requirements

Foreign Trade and International Finance

East Asia

Consumer education

Import restrictions

Imports

Africa (Sub-Saharan)

Governmental investigations

Drug approvals

Drugs

Prescription pricing

Consumer protection

Federal-state relations

Government paperwork

Government publicity

Parties to actions

Restrictive trade practices

Denmark

Portugal

Spain

Internet

Licenses

Administrative procedure

Evidence (Law)

Electronic government information

Web sites

Product safety

Independent regulatory commissions

Injunctions

Identification devices

Telephone

Price discrimination

Finland

Labeling

Patent infringement

Patents

Product counterfeiting

Belgium

Damages

Administrative fees

Punitive damages

Federal Trade Commission

Drug industry

Pharmacies

Packaging

Limitation of actions

Pharmacists

Wholesale trade

Iceland

Luxembourg

Liechtenstein

Austria